Lung Cancer Edition: Top Headlines for Week of April 15, 2024
In this edition, durvalumab improves survival in limited-stage small cell lung cancer, most adults do not test homes for radon exposure and more. Read the full coverage here:
Durvalumab improves survival in limited-stage small cell lung cancer
Survey: Most adults do not test homes for radon exposure, unconcerned about risks
FDA fast tracks investigational bispecific therapy for aggressive lung cancer
Research shows complexity of shared decision-making about lung cancer screening
Keytruda-Lynparza combination misses survival targets in phase 3 lung cancer trial
References:
Núñez E, et al. Ann Fam Med. 2024;doi:10.1370/afm.3081.
Press Release
Press Release.
Press Release
Press Release
Create your
podcast in
minutes
It is Free